Botswana Diamonds shares sparkle as it begins exploration programme with Alrosa
A look at some of today's top risers and fallers in London
Company
LON:ONC
Oncimmune Holdings PLC is a leading immunodiagnostics developer, primarily focused on the growing fields of immuno-oncology, autoimmune disease and infectious diseases. The company has a diversified and growing revenue from its portfolio of diagnostic products to detect early-stage cancer and a contract discovery and development service-based platform, delivering actionable insights into therapies to its pharmaceutical and biotech partners.
139 stories · page 7 of 7
A look at some of today's top risers and fallers in London
Investments and investor services
The index of blue-chip shares ended the day down 0.1% or points at 7,178.01 points after the CPI data
Archive
Day ahead includes trading updates from FTSE 100-listed holidays firm TUI and language support services group RWS Holdings, plus the latest UK inflation numbers
Archive
Week ahead includes the latest UK and US consumer price indexes, plus corporate updates from RELX PLC, Coca Cola HBC PLC, Shire PLC and ConvaTec PLC
The FTSE 100 index was less than a point higher at 7,523, well below the session peak of 7,560.04.
Archive
Only four trading updates or results are in the calendar for Friday...
Archive
The Week Ahead includes economic data on UK jobs, inflation and retail sales along with full year results from ASOS and Bellway and trading updates from Travis Perkins, Merlin Entertainments, Unilever and Intercontinental Hotels Group
FTSE 100 shares closed higher on Friday, led by miners buoyed by strong trade data from China while several UK companies were snapping up US stocks in a role reversal from that seen in the days after the June Brexit poll when UK companies w
Archive
December manufacturing, industrial and construction output numbers, plus latest trade figures, should all illustrate the pressures on British industry since June's Brexit vote.
Aside from the election, several UK retailers have results due next week
Telit wins approval to use its products on a US network, Mosman's diamond venture will begin shortly and Oncimmune receives CE stamp for its early stage lung cancer test.
The agreements will increase the size of the salesforce across the US selling EarlyCDT-Lung to more than 140